Search Results - useful

5 Results Sort By:
Conformation Dependent Anti-major Outer Membrane Protein (MOMP) Monoclonal Antibody BD5
A murine hybridoma expressing mAb BD3 was found to react with a conformationally dependent epitope on the chlamydial Major Outer Membrane Protein (MOMP), a primary target of neutralizing antibodies and vaccine development. The BD3 neutralized the in vitro infectivity of C. trachomatis serovars B, Ba, D, E, L2. It is useful for verifying the correct...
Published: 10/28/2024   |   Inventor(s): Harlan Caldwell
Keywords(s): Against, ANTIBODY, Anti-major, B, ba, BD5, Chlamydia, CONFORMATION, Correct, D, Dependent, e, Hybridoma, L2, Listed LPM Thalhammer-Reyero as of 4/15/2015, Mab, MEMBRANE, MOMP, monoclonal, OUTER, Post LPM Assignment Set 20150420, Pre LPM working set 20150418, Protein, RM, SEROVARS, TRACHOMATIS, USEFUL, vaccines, Verifying, WIXXXX
Category(s): Collaboration Sought > Licensing, Application > Research Materials
Enterovirus Molecular Diagnostic Test Kit
CDC researchers have developed a reverse transcription/semi-nested polymerase chain reaction (RT-snPCR) assay for diagnosis of enterovirus infections within clinical specimens. Clinical laboratories currently identify enteroviruses by virus isolation and subsequent virus neutralization tests, or serological assays. In addition to being time consuming,...
Published: 10/28/2024   |   Inventor(s): Mark Oberste, William Nix
Keywords(s): Acid, CDC Docket Import, CDC Docket Import CDC Prosecuting, DA4BXX, DA4XXX, DAXXXX, DETECTING, DXXXXX, Enteroviruses, Identifying, Including, Kits, MOLECULES, Nucleic, OID-NCIRD-DVD, USEFUL, VLXXXX, VOXXXX, VP1, VP3, WBXXXX, WFXXXX, WIXXXX, WMXXXX, XCXXXX, XEXXXX, YBXXXX
Category(s): Collaboration Sought > Licensing, Application > Diagnostics, Application > Occupational Safety and Health, Application > Research Materials, TherapeuticArea > Infectious Disease, Application > Consumer Products, Application > Therapeutics
Attenuated Human Parainfluenza Virus (PIV) for Use as Live, Attenuated Vaccines and as Vector Vaccines
The identified technologies describe self-replicating infectious recombinant paramyxoviruses with one or more attenuating mutations, such as a separate variant polynucleotide encoding a P protein and a separate monocistronic polynucleotide encoding a V protein, or at least one temperature sensitive mutation and one non-temperature sensitive mutation....
Published: 10/28/2024   |   Inventor(s): Peter Collins, Sheila Nolan, Mario Skiadopoulos, Brian Murphy
Keywords(s): cDNA, CIS-ACTING, Complete, DC5BXX, DC5XXX, DCXXXX, Determination, DXXXXX, FOR..., FRAMES, Gene, Generate, Generation, Genomic, HPIV2, HPIV2., HPIV2/V94, Identification, MEASLES, Mumps, MUTATION, Novel, Nucleotide, Overlapping, P/V, Parainfluenza virus type 3, Parainfluenza virus type 3; Human parainfluenza virus type 3, Reading, recombinant, rHPIV2, Separated, sequence, Strain, UA1XXX, USEFUL, V94
Category(s): Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Rare / Neglected Diseases, Application > Vaccines, TherapeuticArea > Infectious Disease
Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses
Although flaviviruses cause a great deal of human suffering and economic loss, there is a shortage of effective vaccines. This invention relates to dengue virus mutations that may contribute to the development of improved dengue vaccines. Site directed and random mutagenesis techniques were used to introduce mutations into the dengue virus genome...
Published: 10/28/2024   |   Inventor(s): Joseph Blaney, Kathryn Hanley, Brian Murphy, Stephen Whitehead
Keywords(s): ATTENUATING, chimeric, DC5BXX, DC5XXX, DCXXXX, DENGUE, Dengue (Flaviviridae), Dengue Vaccine, Development, DXXXXX, Mutations, UAXXXX, UBXXXX, USEFUL, Viruses
Category(s): Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Vaccines, TherapeuticArea > Rare / Neglected Diseases, TherapeuticArea > Infectious Disease
A Novel Adeno-Associated Virus for Gene Therapy
Scientists at the NIH disclosed a novel adeno-associated virus (AAV) termed "44-9." AAV44-9 based vectors have high gene transfer activity in a number of cell types, including salivary gland cells, liver cells, and different types of neurons (e.g., cells of the cortex, olfactory bulb, and brain stem, and Purkinje cells of the cerebellum). These vectors...
Published: 10/28/2024   |   Inventor(s): Giovanni Di Pasquale, John (Jay) Chiorini
Keywords(s): AAV, CHARACTERIZATION, Gene, Generation, Listed LPM Hu as of 4/17/2015, Novel, Post LPM Assignment Set 20150420, Pre LPM working set 20150418, THERAPY, USEFUL, VAXXXX, VCXXXX, VEXXXX, VFXXXX, VGXXXX, WJXXXX, XEXXXX, YBXXXX, YCXXXX
Category(s): TherapeuticArea > Neurology, TherapeuticArea > Immunology, TherapeuticArea > Endocrinology, TherapeuticArea > Oncology, TherapeuticArea > Geriatrics, Application > Therapeutics